Home 2024
Archives
Exposure to Libby Amphibole: The clinical picture of autoimmune disease
Karen Lee Morrissette and Jean C. Pfau from the Center for Asbestos-Related Disease discuss the clinical presentation and complexity of the autoimmune disease progression among those exposed to Libby Amphibole.
Lessons from Libby: Understanding the impact of asbestos exposure
Jean C. Pfau, Scientific Consultant at the Center for Asbestos Related Disease, shares the devasting story of asbestos exposure occurring in a Rocky Mountain town of Montana and the critical lessons that can be learned from this event.
Great leaps in multiple sclerosis treatment but the holy grail is still ahead
CEO of MS Australia Rohan Greenland highlights the breakthroughs in treating attacks on the brain and spinal cord in multiple sclerosis (MS). But his sights are set firmly on the great unmet needs: to repair damaged nerves, reverse disability, and ultimately, prevent MS.
Information overload and the ossification of immunological research
Peter Bretscher, Faculty in the Department of Biochemistry, Microbiology and Immunology at the University of Saskatchewan questions whether there is a way of fostering resilience in immunological research.
Preventing autoimmune diabetes in genetically susceptible people
Department of Biochemistry - Microbiology and Immunology - University of SaskatchewanCan we now envisage antigen-specific therapies to prevent and treat organ-specific autoimmune diseases, such as autoimmune diabetes?
Identifying adult-onset type 1 diabetes
Liping Yu, at the Barbara Davis Center for Diabetes, highlights how we can recognise and diagnose adult-onset type 1 diabetes.